《亞洲股市》中港股市早段反覆回升0.6%至0.8% 日經偏軟
美股隔晚(29日)繼續個別發展,美國經濟數據表現參差,但早期研究指出,Omicron病例的住院風險降低,紓緩市場對疫情惡化憂慮,且統計顯示,美國商店人流在假期旺季升至疫情前水平,零售股及醫藥護理股有買盤,逾三分之二藍籌也造好,帶動道指六連漲兼曾突破11月初所創紀錄高位36,565,最高見36,571,收36,488,升90點或近0.2%,標指反覆回升0.1%;據報正獲南韓三星洽購的美國生物公司渤健(Biogen)(BIIB.US)股價升9.5%,但Salesforce(CRM.US)、亞馬遜(AMZN.US)及Meda(FB.US)受壓,拖累納指反覆續跌0.1%。此外,富時長假後復市追升近0.7%;但泛歐600及歐元區主要股市反覆回吐0.1%至0.7%,其中法國CAC高見7,201屢創紀錄高後倒跌0.3%。
美股期貨變動不大。亞太區股市今早(30日)個別發展。美元兌日圓於亞洲續微升至115.04,但日經反覆續軟,最高見28,904,現報28,862,續跌44點或0.2%。澳洲200繼昨天覆市續升1.2%後,今早反覆回軟,最高見7,520,現報7,505,微跌4點。星股兩連升後,今早反覆微跌不足0.1%,報3,135。
然而,滬指及深成繼昨天低收回吐0.9%及1.2%後,今早輕微低開,現報3,617及14,772,回升0.6%及0.8%。
港股繼昨天回吐0.8%結束五連升後,今天期結日恆指高開43點或0.2%,報23,130,掉頭曾倒跌36點低見23,050獲承接,在三大重磅新經濟股在騰訊(00700.HK)、阿裏(09988.HK)及美團(03690.HK)反彈帶動,最高見23,228,現報23,231,回升144點或0.6%。
韓股繼昨天回吐0.9%後,今早反覆回穩,高低分別見3,005及2,986,現報2,996,回升0.1%。臺灣加權指數連升第八天,今天反覆高見18,291屢創紀錄高,現報18,268,升0.1%。新西蘭50指數報13,003,續升0.5%。馬來西亞吉隆坡綜合指數續升0.1%,報1,546。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.